Home » Topics » BioWorld Science

BioWorld Science
RSS

pH Pharma and Immunome collaborate to discover ADCs for cancer

Oct. 22, 2019

First patient with IPF dosed in phase I study of IDL-2965

Oct. 22, 2019

Imugene provides update on its CF-33 oncolytic virus clinical program

Oct. 22, 2019

C-781: a promising compound for mechanical allodynia

Oct. 22, 2019

Suven Life Sciences presents preclinical data for SUVN-A6077

Oct. 22, 2019

First-in-human data presented for NJA-730

Oct. 22, 2019

Identification of first FA-T case caused by homozygous missense variants in UBE2T

Oct. 22, 2019

VWA2 identified as a novel autosomal recessive gene candidate in AD

Oct. 22, 2019

Two novel mutations in the HIBCH gene linked to HIBCH deficiency

Oct. 22, 2019

Slc7a7 knockout mice display features of lysinuric protein intolerance

Oct. 22, 2019

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 18, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 18, 2025.
Apollo’s APL-4098 shows potent antileukemic effects
BioWorld Science
Apollo Therapeutics Ltd. has developed APL-4098, a small-molecule general control nonderepressible 2 (GCN2) inhibitor for the potential treatment of AML.
ABS-1230 controls seizures in KCNT1-driven severe epilepsy
BioWorld Science
Mutations in the KCNT1 gene produce gain-of-function effects that lead to overactivation of the potassium channel and consequent disruption of normal neuronal...
DEE-lightful: Praxis’ phase II results allow stock to flex its muscle
BioWorld
Positive efficacy results led to Praxis Precision Medicines Inc.’s phase II Embold study in developmental and epileptic encephalopathies (DEEs) being halted...